Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer.

× No keyword cloud information.

9 in total

1. Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.

Authors: Tristan M Sissung; Ariel M Ley; Jonathan D Strope; Edel M McCrea; Shaunna Beedie; Cody J Peer; Suneet Shukla; Jennifer van Velkinburgh; Kelie Reece; Sarah Troutman; Tessa Campbell; Elena Fernandez; Phoebe Huang; Jordan Smith; Nilay Thakkar; David J Venzon; Stefan Brenner; Wooin Lee; Maria Merino; Ji Luo; Walter Jager; Douglas K Price; Cindy H Chau; William D Figg
Journal: Mol Cancer Res Date: 2017-04-07 Impact factor: 5.852

2. Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate Cancer.

Authors: G Celine Han; Justin Hwang; Stephanie A M Wankowicz; Zhenwei Zhang; David Liu; Carrie Cibulskis; Glenn C Gaviola; Varand Ghazikhanian; Rana R McKay; Glenn J Bubley; Scott L Carter; Steven P Balk; William C Hahn; Mary-Ellen Taplin; Eliezer M Van Allen
Journal: JCO Precis Oncol Date: 2017-12-11

3. Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.

Authors: Ramakumar Tummala; Wei Lou; Allen C Gao; Nagalakshmi Nadiminty
Journal: Mol Cancer Ther Date: 2017-07-20 Impact factor: 6.261

4. Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.

Authors: Kristina Stuopelyte; Rasa Sabaliauskaite; Arnas Bakavicius; Benedikta S Haflidadóttir; Tapio Visakorpi; Riina-Minna Väänänen; Chintan Patel; Daniel C Danila; Hans Lilja; Juozas R Lazutka; Albertas Ulys; Feliksas Jankevicius; Sonata Jarmalaite
Journal: J Urol Date: 2020-02-18 Impact factor: 7.450

Review 5. Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview.

Authors: Min Liu; Hongzhe Shi; Jiaqing Yan; Yuan Zhang; Yinglin Ma; Kaidi Le; Zhongdong Li; Nianzeng Xing; Guohui Li
Journal: Am J Cancer Res Date: 2021-05-15 Impact factor: 6.166

Review 6. Resistance to second-generation androgen receptor antagonists in prostate cancer.

Authors: Keith T Schmidt; Alwin D R Huitema; Cindy H Chau; William D Figg
Journal: Nat Rev Urol Date: 2021-03-19 Impact factor: 14.432

Review 7. Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer.

Authors: Jin Xu; Yun Qiu
Journal: Asian J Androl Date: 2019 May-Jun Impact factor: 3.285

8. Targeted non AR mediated smart delivery of abiraterone to the prostate cancer.

Authors: Abu Baker; Mohammad Khalid; Imran Uddin; Mohd Sajid Khan
Journal: PLoS One Date: 2022-08-26 Impact factor: 3.752

Review 9. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.

Authors: Joshua Altschuler; Jennifer A Stockert; Natasha Kyprianou
Journal: Int J Mol Sci Date: 2021-02-20 Impact factor: 5.923

9 in total